Work

Trends in viral load and CD4 cell count monitoring among adults with HIV in the Asia-Pacific region: A multicentre observational cohort study of the TREAT Asia HIV Observational Database, 2003–2018

Year: 2026
Type: article
Abstract: INTRODUCTION: Viral load (VL) testing is recommended for monitoring antiretroviral therapy (ART), whereas CD4 testing is increasingly targeted. Changes in these practices across Asia-Pacific remain unclear. We examined trends in VL and CD4 testing rates and their associations with AIDS diagnosis and mortality. METHODS: We analysed multicentre cohort data from adults receiving ART during 2003-2018 using Poisson and Fine-Gray competing-risk regression. RESULTS: Among 8,446 patients, VL testing rates remained steady at one test per person-year during 2003-2018. Increased VL testing was associated with more frequent CD4 testing (>2 tests in the previous year; incidence rate ratio (IRR)=1.57, 95%CI 1.53-1.60), later follow-up years (2008-2012: IRR = 1.15, 95%CI 1.12-1.18; 2013-2015: IRR = 1.07, 95%CI 1.04-1.10), older age (31-40years: IRR = 1.06, 95%CI 1.03-1.08; 41-50years: IRR = 1.08, 95%CI 1.05-1.11; > 50years: IRR = 1.07, 95%CI 1.03-1.11), higher current VL (401-1000 copies/mL: IRR = 1.16, 95%CI 1.09-1.24; > 1000 copies/mL: IRR = 1.07, 95%CI 1.04-1.11), initial ART regimen (nucleoside/nucleotide reverse transcriptase inhibitor plus protease inhibitor (NRTI+PI): IRR = 1.07, 95%CI 1.04-1.10; other combinations: IRR = 1.11, 95%CI 1.05-1.17), and higher country income levels (upper-middle: IRR = 2.17, 95%CI 2.11-2.23; high: IRR = 3.14, 95%CI 3.03-3.26). CD4 testing rates decreased from 2.04 to 1.06 tests per person-year over the same period. Lower CD4 testing rate was associated with HIV exposure mode (men who have sex with men (MSM): IRR = 0.94, 95%CI 0.92-0.96; injecting drug use (IDU): IRR = 0.93, 95%CI 0.90-0.97; other/unknown: IRR = 0.90, 95%CI 0.87-0.93), higher current CD4 (201-350 cells/µL: IRR = 0.95, 95%CI 0.93-0.97; 351-500 cells/µL: IRR = 0.89, 95%CI 0.87-0.91; > 500 cells/µL: IRR = 0.85, 95%CI 0.83-0.87) and receiving an NRTI+PI first-line combination (IRR = 0.96, 95% CI 0.94-0.98). VL and CD4 testing rates were not significantly associated with AIDS diagnosis. However, having >2 CD4 tests in the previous year was associated with higher mortality risk. CONCLUSION: VL testing was broadly consistent with annual monitoring, although individual gaps may remain. Differentiated strategies should maintain annual VL testing and targeted CD4 testing for advanced HIV disease.
Source: PLoS ONE
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W7140142585
FWCI:
Cites: 25
Cited by:
Related to: 9
Parts: 18